We are monitoring the impact of COVID-19 on MEA Aptamers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1076
Share on
Share on

Middle East & Africa Aptamers Market Research Report - Segmented By Type, Application, End User, & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1076
Pages: 145

MEA Aptamers Market Size (2020 to 2025):

The size of the Middle East & Africa Aptamers Market is valued at USD 13.16 million in 2020 and estimated to reach USD 16.15 million by the end of 2025, growing at a CAGR of 4.23% from 2020 to 2025.

The numerous opportunities offered by the market are drug discovery, biomarker discovery, and diagnostics segments due to the high efficacy of aptamers and doesn’t cause any immunological reactions and low manufacturing cost. They are used as therapeutic tools and biosensors. The effectiveness of aptamers and the low cost of manufacturing can provide treatment for diseases like HIV or AIDS to the poorest/low-income countries. The development of aptamers is faster than antibodies which helps to cures the disease faster.

The Middle East and Africa market are driven by the low cost of manufacturing, high efficacy of aptamers in binding, advanced technologies, increasing R&D investments in pharmaceutical and biotechnology industries. The restraints that are hindering the growth of the market are Ethical issues for the aptamers that are obtained from animals, stringent regulations in the use of aptamers. In the following years, the market is projected to grow enormously with Low cost of manufacturing, high efficacy of aptamers.

This research report segmented and sub-segmented the Middle East & Africa Aptamers Market into the following categories:

By Type: 

  • Peptide aptamers
  • Nucleic Acid aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers

By  Application: 

  • Therapeutics Development
  • Diagnostics
  • Research and Development

By End User: 

  • Pharmaceutical Companies
  • Bio-Pharmaceutical companies
  • Academic and Research Centres

By Country: 

  • KSA
  • UAE
  • Israel
  • the rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Some of the top companies leading the Middle East & Africa Aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Aptamers Market, By Type, From 2020 to 2025 (USD Million)
  2. Middle East & Africa Peptide Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  3. Middle East & Africa Nucleic Acid Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  4. Middle East & Africa Aptamers Market, By Application, From 2020 to 2025 (USD Million)
  5. Middle East & Africa Therapeutics Development Market, By Region, From 2020 to 2025 (USD Million)
  6. Middle East & Africa Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  7. Middle East & Africa Research and Development Market, By Region, From 2020 to 2025 (USD Million)
  8. Middle East & Africa Aptamers Market, By End users, From 2020 to 2025 (USD Million)
  9. Middle East & Africa Pharmaceutical Companies Market, By Region, From 2020 to 2025 (USD Million)
  10. Middle East & Africa Bio-Pharmaceutical Companies Market, By Region, From 2020 to 2025 (USD Million)
  11. Middle East & Africa Academic and Rsearch centers Market, By Region, From 2020 to 2025 (USD Million)
  12. Middle East Aptamers Market, By Type, From 2020 to 2025 (USD Million)
  13. Middle East Aptamers Market, By Application, From 2020 to 2025 (USD Million)
  14. Middle East Aptamers Market, By End users, From 2020 to 2025 (USD Million)
  15. Africa Aptamers Market, By Type, From 2020 to 2025 (USD Million)
  16. Africa Aptamers Market, By Application, From 2020 to 2025 (USD Million)
  17. Africa Aptamers Market, By End users, From 2020 to 2025 (USD Million)
  18. Middle East & Africa Aptamers Market, By Nucleic Acid Aptamers, From 2020 to 2025 (USD Million)
  19. Middle East & Africa DNA Based Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  20. Middle East & Africa RNA Based Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  21. Middle East & Africa XNA Based Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  22. Middle East Aptamers Market, By Nucleic Acid Aptamers, From 2020 to 2025 (USD Million)
  23. Africa Aptamers Market, By Nucleic Acid Aptamers, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample